Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Researchers' work from Ankara University, Medical Department focuses on renal cell carcinoma
May 28th, 2009
According to a study from Ankara, Turkey, "For many years, cytokines have been utilised in treatment of metastatic renal cell carcinoma (mRCC), with limited response rates and significant side-effects. Recently, several targeted agents have demonstrated clinical efficacy in the treatment of mRCC." "To discuss the applicability of previously described prognostic factors in patients with mRCC who are starting targeted therapy. Evidence acquisition: Clinical data on prognostic factors and patient stratification strategies are reviewed. Evidence synthesis: During the cytokine era, time from diagnosis to treatment, Karnofsky performance status (PS), serum lactate...
Source: Women's Health Weekly (2009-05-28)
|
